Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Reduced Serum Uric Acid Levels May Protect Against Renal Function Decline

  |  

The authors concluded their paper by suggesting that aggressive serum acid-lowering approaches may be helpful in slowing the progression of renal disease.

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Desai RJ, Franklin JM, Spoendlin-Allen J, et al. An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout. PLoS One. 2018 Feb 28;13(2):e0193622. eCollection 2018.

Related Articles

    Canakinumab Reduces Risk for Gout Flares, But Not Serum Uric Acid Levels

    An exploratory analysis of a canakinumab clinical trial has shown the interleukin 1β inhibitor may significantly reduce patients’ risk for gout flares. During the study, patients using canakinumab experienced this decreased risk, but the treatment did not change serum uric acid levels…

    Study Finds Renal Arteriosclerosis Is Common in Lupus Nephritis Patients

    Renal arteriosclerosis is common in lupus patients with nephritis and occurs two decades earlier than it does in people without lupus nephritis (LN), report investigators in a study that examined the prevalence of renal arteriosclerosis in LN patients compared with healthy controls.1  The finding suggests that renal arteriosclerosis could be used as a biomarker for…